Female Reproductive System Adenosquamous Carcinoma

Female Reproductive System Adenosquamous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 4
Ph III recruiting: 1
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–20 of 20 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01935934	Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	completed	Phase 2	102	National Cancer Institute (NCI)NIH	2	Oct 1, 2025	clinicaltrials
NCT02921269	Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer	completed	Phase 2	11	National Cancer Institute (NCI)NIH	1	Feb 21, 2023	clinicaltrials